Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - Nasdaq - US4570301048 - Common Stock - Currency: USD

66.31  -0.45 (-0.67%)

After market: 65.35 -0.96 (-1.45%)

Fundamental Rating

4

Taking everything into account, IMKTA scores 4 out of 10 in our fundamental rating. IMKTA was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of IMKTA get a neutral evaluation. Nothing too spectacular is happening here. IMKTA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IMKTA had positive earnings in the past year.
IMKTA had a positive operating cash flow in the past year.
IMKTA had positive earnings in each of the past 5 years.
Each year in the past 5 years IMKTA had a positive operating cash flow.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of IMKTA (2.47%) is comparable to the rest of the industry.
IMKTA has a Return On Equity of 3.94%. This is in the lower half of the industry: IMKTA underperforms 60.00% of its industry peers.
IMKTA has a worse Return On Invested Capital (4.06%) than 62.50% of its industry peers.
IMKTA had an Average Return On Invested Capital over the past 3 years of 10.21%. This is in line with the industry average of 8.23%.
The 3 year average ROIC (10.21%) for IMKTA is well above the current ROIC(4.06%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROIC 4.06%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

IMKTA has a Profit Margin (1.14%) which is in line with its industry peers.
IMKTA's Profit Margin has been stable in the last couple of years.
The Operating Margin of IMKTA (2.20%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IMKTA has declined.
IMKTA's Gross Margin of 23.50% is in line compared to the rest of the industry. IMKTA outperforms 50.00% of its industry peers.
IMKTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMKTA is creating some value.
IMKTA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for IMKTA has been reduced compared to 5 years ago.
IMKTA has a better debt/assets ratio than last year.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

IMKTA has an Altman-Z score of 4.30. This indicates that IMKTA is financially healthy and has little risk of bankruptcy at the moment.
IMKTA has a Altman-Z score of 4.30. This is comparable to the rest of the industry: IMKTA outperforms 57.50% of its industry peers.
IMKTA has a debt to FCF ratio of 24.41. This is a negative value and a sign of low solvency as IMKTA would need 24.41 years to pay back of all of its debts.
With a Debt to FCF ratio value of 24.41, IMKTA is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.32 indicates that IMKTA is not too dependend on debt financing.
IMKTA's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. IMKTA outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Altman-Z 4.3
ROIC/WACC0.56
WACC7.2%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

IMKTA has a Current Ratio of 3.19. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.19, IMKTA belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
A Quick Ratio of 1.46 indicates that IMKTA should not have too much problems paying its short term obligations.
IMKTA has a better Quick ratio (1.46) than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 1.46
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

The earnings per share for IMKTA have decreased strongly by -64.88% in the last year.
IMKTA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.65% yearly.
The Revenue has decreased by -7.79% in the past year.
IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.06% yearly.
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

IMKTA is valuated rather expensively with a Price/Earnings ratio of 20.34.
IMKTA's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of IMKTA to the average of the S&P500 Index (27.45), we can say IMKTA is valued slightly cheaper.
Industry RankSector Rank
PE 20.34
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMKTA is valued a bit cheaper than 80.00% of the companies in the same industry.
70.00% of the companies in the same industry are cheaper than IMKTA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 58.63
EV/EBITDA 6.09
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.06
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

IMKTA has a yearly dividend return of 1.00%, which is pretty low.
Compared to an average industry Dividend Yield of 2.03, IMKTA pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.00, IMKTA pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.12%.
IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
IMKTA has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

19.81% of the earnings are spent on dividend by IMKTA. This is a low number and sustainable payout ratio.
IMKTA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP19.81%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (7/3/2025, 7:37:42 PM)

After market: 65.35 -0.96 (-1.45%)

66.31

-0.45 (-0.67%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners92.45%
Inst Owner Change2.03%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.26B
Analysts84.44
Price TargetN/A
Short Float %4.66%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 1%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP19.81%
Div Incr Years0
Div Non Decr Years11
Ex-Date07-10 2025-07-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.34
Fwd PE N/A
P/S 0.23
P/FCF 58.63
P/OCF 6.43
P/B 0.8
P/tB 0.8
EV/EBITDA 6.09
EPS(TTM)3.26
EY4.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.13
FCFY1.71%
OCF(TTM)10.32
OCFY15.56%
SpS284.91
BVpS82.77
TBVpS82.77
PEG (NY)N/A
PEG (5Y)3.06
Profitability
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROCE 5.36%
ROIC 4.06%
ROICexc 4.69%
ROICexgc 4.69%
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
FCFM 0.4%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
ROICexc(3y)11.97%
ROICexc(5y)12.99%
ROICexgc(3y)11.97%
ROICexgc(5y)12.99%
ROCE(3y)13.5%
ROCE(5y)15.58%
ROICexcg growth 3Y-23.42%
ROICexcg growth 5Y-0.13%
ROICexc growth 3Y-23.42%
ROICexc growth 5Y-0.13%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score5
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Debt/EBITDA 2.07
Cap/Depr 139.43%
Cap/Sales 3.22%
Interest Coverage 250
Cash Conversion 80.23%
Profit Quality 34.67%
Current Ratio 3.19
Quick Ratio 1.46
Altman-Z 4.3
F-Score5
WACC7.2%
ROIC/WACC0.56
Cap/Depr(3y)141.53%
Cap/Depr(5y)130.04%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.87%
Profit Quality(5y)73.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.02%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.85%
FCF growth 3Y-32.19%
FCF growth 5Y0.76%
OCF growth 1Y-29.62%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%